Form 4 for ZBIO Zenas BioPharma, Inc.
Accepted 2026-06-17 18:00:32 ET · period of report 2026-06-15 · accession 0001104659-26-075250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-17 18:00 | 2026-02-05 | ZBIO | Farmer Joseph L | See Remarks | A - Grant | $13.35 | +974 | 974 | New | +$13.0K |
| D | 2026-06-17 18:00 | 2026-06-15 | ZBIO | Farmer Joseph L | See Remarks | A - Grant | $0.00 | +175.0K | 175.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-05 | A | A | 974 | $13.35 | 974 | D | — | — | (F1) Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c). |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-15 | A | A | 175,000 | $0.00 | 175,000 | D | $18.71 · — to 2036-06-15 | 175,000 Common Stock | (F2) The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service. |